Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exciting times!!
47 days until the last business day in June
I would think we are at minimum 2-3 years away from uplisting. Will be a great ride - I'm confident we get there unless 1 of 2 things happen:
1. We don't get IDE (doubt this happens)
2. Big pharma buys the company
The future is brighter than ever, for longs and cancer patients.
If we have a volatile week next week, I will take advantage of any dips below 18 cents to buy another lot.
If we run to 30 cents as you predict...I will enjoy the ride
Beautiful close. Exciting times! If we drop back to 15-17 range I have some dry powder ready to buy another 20k or so.
I think the Benzinga article would be best right after they submit the IDE. My 2 cents...
Smart money knows that but some are here for the quick flip. Also, some longs have millions of shares at cost averages in the 3 cent range. I can't blame them for trimming some shares, if any of them are doing so.
Instead, I see any drop as a temporary discount on potentially very valuable shares. I have a buy order in to add to my 300k shares. This is my second time buying since RDGL pushed out a timeline for submission. Might move money tomorrow to throw the kitchen sink at this ticker.
How did I miss that!! Hello meme city and articles after IDE approval. This really is a multi billion dollar company!
Anyone who wants an almost guaranteed return look at RDGL.
Bottom of page 25 of Q report is awesome, RDGL should put this info out as a meme/Tweet:
"The MAB selected 18 applications for RadioGel™, each of which meet the criteria described above. This large number confirms the wide applicability of the device and defines the path for future business growth..."
Tomorrow we will see if the Tweet is enough to bring in more buyers...if not, could keep sliding down.
I would expect June. If they submit this month, even better!!!
Great post! Sticky_this_please
Bold...
I wasn't posting in response to a post of yours.
Buying now you will make a nice return come August. A few days or cents in either direction isn't a big deal imo.
All this is assuming they submit IDE by end of June and get approval by July 30.
The way this is going 15 will be here sooner than later. Wish it wasn't dropping but if you want more shares - buy on the dips!!!
That is me. I've been burned on the OTC too many times so I jumped out. Wish we would have held 8s but it is what it is.
Still watching this ticker and will maybe jump back in even if I have to chase...
Good points, appreciate the insight
I hope everyone on this board who have been so convinced that their posts affect the share price, see what is happening now and realize 99% of the price action has ZERO to do with what is said on iHub and Stocktwits.
Lots of flippers made the last run what it was. Now they are taking their profits. I wish they were all longs because if they were, I think we would still be holding a higher share price.
55 days or less to IDE submission as lomg as they stick to their announcements of getting IDE submitted to FDA by end of Q2.
Lol
The company has to tell us, per SEC rules, within 5 days of a material event. Submittal of IDE is a material event and they will push out a Tweet and likely an article.
Some of the conjecture on this board is beyond funny, it's sad.
You and me both! I do have one lot of 10k at 5 and another 10k lot at 4.9, Most of my lots are in the 7s. Guess I was just holding on when we were down that low for the most part.
As others have pointed out, volume is low, so we should find ourselves in a trading channel. Hopefully, we climb up to 20 cents and that is the new floor.
Either way, the low volume means most are holding and price fluctuations mean less.
I can't wait until RDGL says all of the reports and reviews are complete and they are submitting the IDE. Volume and price will explode.
May our approval for IDE arrive sooner than later...lives depend on this!!
Oh man, I'm sorry to hear about your loss. Appreciate the support.
May our road to human approval be as soon as possible
A really close friend of mine just got diagnosed today with esophageal cancer.
The sooner this is helping humans, the better. Even if it can't help him, it can help others.
Great post - thank you! Realistic timelines and price ranges.
Your post has me 🤩 @ the future.
RDGL killing cancer from the inside out
Dreamy price target🤑
There is a catalyst that started this run. When RDGL put out the chart that said IDE in Q2, that was the beginning. All the other updates related to IDE have just kept adding fuel to the fire. Just sayin...
I've been calling that for a while (IDE submission middle to late June). RDGL often misses their timelines (Benzinga article by mid-April as an example), so I hope they don't miss this one.
If they don't submit by 28 June (last business day in the Q), share price will crash back down to 10 cent level or lower.
I can't believe this is holding a penny. The longer it takes for this company to show results the more it looks like a scam...just my 2 cents
Today we might close red based on the trading I see in L2 so far. Looks like flippers want to flip....
Don't forget RDGL sent the report to a 3rd party to review per FDA request. That will take some time. My guess is mid-June for submission.
Good deal. I thought you were getting impatient and wanted to make sure you knew it was going to be a couple more weeks.
We closed green! 🤩🔥
She had to cool off a bit. Healthy action imo. Likely back to the races tomorrow, and if not, tomorrow, Monday.
Again with the over the top predictions? Lol. Have fun, Konshe, but reality is still ruling our share price
Back when they submitted the BDD, we had several multimillion dollar days.
I'd love that! Just don't see that happening today.
Today? Close at $0.23